Title: Dose optimization is effective in ulcerative colitis patients losing response to infliximab: A collaborative multicentre retrospective study
Authors: Cesarini, Monica ×
Katsanos, Konstantinos
Papamichael, Konstantinos
Ellul, Pierre
Lakatos, Peter L
Caprioli, Flavio
Kopylov, Uri
Tsianos, Epameinondas
Mantzaris, Gerassimos J
Ben-Horin, Shomron
Danese, Silvio
Fiorino, Gionata #
Issue Date: Feb-2014
Publisher: Editrice gastroenterologica italiana
Series Title: Digestive and Liver Disease vol:46 issue:2 pages:135-9
Article number: 10.1016/j.dld.2013.10.007
Abstract: Subjects maintained on infliximab scheduled therapy for inflammatory bowel disease may require dose optimization due to secondary loss of response. There are limited data on infliximab dose optimization for ulcerative colitis.
ISSN: 1590-8658
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Non-KU Leuven Association publications
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science